Antidepressant Self-Discontinuation: Results From the Collaborative Psychiatric Epidemiology Surveys
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The goal of this study was to examine the extent and correlates of self-discontinuation of antidepressant medications without physician advice. METHODS: Among 1,411 participants of the nationally representative Collaborative Psychiatric Epidemiology Surveys who reported using antidepressants in the past year, sociodemographic and clinical correlates of self-discontinuation of medication without physician advice or approval were examined, along with participants' reasons for discontinuation. RESULTS: A total of 313 (22%) antidepressant users in the preceding year reported discontinuing their antidepressant medication without physician advice or approval. Older individuals had reduced odds of self-discontinuing antidepressants. Participants with an anxiety or substance use disorder and those prescribed an antidepressant by a provider other than a psychiatrist had higher odds of self-discontinuation. Participants with public insurance had lower odds of self-discontinuation than those with private insurance. The two most commonly reported reasons for self-discontinuation of antidepressants were side effects and experiencing no benefit from the medication. CONCLUSIONS: Physicians prescribing antidepressants need to clearly communicate the expected benefits of treatment, the minimum duration of use required to experience benefits, and the potential side effects of these medications, particularly to younger patients, those with anxiety disorders, and patients treated in general medical settings, all of whom have increased odds of self-discontinuation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies of individuals who discontinue medication are generally limited to a single class of medication (3,5,6), with most participants using medication for less than six months (2).”
From Discontinuing Psychiatric Medications: A Survey of Long-Term Users (2017) · cites this paper as [3]
In the citing paper
“In practice, many individuals discontinue use at some point in treatment (3,4), and effective treatment decisions should include information on the risks and benefits of using or not using medications, as well as the option to discontinue.”
From Discontinuing Psychiatric Medications: A Survey of Long-Term Users (2017) · cites this paper as [3]
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Wittchen, H.-U. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90036-1 · Cited by 2,348
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
The quality of care for depressive and anxiety disorders in the United States
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.1.55 · Cited by 1,061
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Jackson, J. S., Torres, M., Caldwell, C. H., Neighbors, H. W., Nesse, R. M., Taylor, R. J., Trierweiler, S. J., & Williams, D. R. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.177 · Cited by 859
Sample designs and sampling methods for the Collaborative Psychiatric Epidemiology Studies (CPES)
Heeringa, S. G., Wagner, J., Torres, M., Duan, N., Adams, T., & Berglund, P. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.179 · Cited by 758
Considering context, place, and culture: the national Latino and Asian American study
Alegria, M., Takeuchi, D., Canino, G., Duan, N., Shrout, P., Meng, X., Vega, W., Zane, N., Vila, D., Woo, M., et al. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.178 · Cited by 733
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730
The National Comorbidity Survey Replication (NCS‐R): background and aims
Kessler, R. C., & Merikangas, K. R. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.166 · Cited by 723
Research works printed but not linked: 5
- Rivero-Santana A, 2013, Journal of Patient Preference and Adherence, 7, 151
- 1994, Diagnostic and Statistical Manual of Mental Disorders
- 2011, Stata Statistical Software: Release 12
- Middleton DJ, 2011, Quality in Primary Care, 19, 109
- 10.1176/ps.2006.57.5.673 · doi:10.1176/ps.2006.57.5.673 · Paper page
Cited by
Kopschina Feltes, P., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A., Moriguchi-Jeckel, C. M., & de Vries, E. F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711708 · Cited by 279
“Side effects were reported by 20% of the patients as the main cause of discontinuation (Samples and Mojtabai, 2015).”
BackgroundAdvances in Psychotherapy for Depressed Older Adults
Raue, P. J., McGovern, A. R., Kiosses, D. N., & Sirey, J. A. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0812-8 · Cited by 111
Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial
Sirey, J. A., Banerjee, S., Marino, P., Bruce, M. L., Halkett, A., Turnwald, M., Chiang, C., Liles, B., Artis, A., Blow, F., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3047 · Cited by 87
Rossom, R. C., Shortreed, S., Coleman, K. J., Beck, A., Waitzfelder, B. E., Stewart, C., Ahmedani, B. K., Zeber, J. E., & Simon, G. E. (2016) · Depression and Anxiety · doi:10.1002/da.22532 · Cited by 77
“, cessation due to side effects or lack of benefit or, alternatively, remission of depression) and unplanned discontinuation of antidepressants, an important distinction.[46] There is growing evidence in the field of ethnic psychopharmacology that variations in genetic and nongenetic mechanisms that alter pharmacokine…”
BackgroundDiscontinuing Psychiatric Medications: A Survey of Long-Term Users
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201700070 · Cited by 62
Srimongkon, P., Aslani, P., & Chen, T. F. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s160728 · Cited by 43
Nestoriuc, Y., Pan, Y., Kinitz, T., Weik, E., & Mora, M. C. S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.587122 · Cited by 39
Ormsby, S., Smith, C. A., Dahlen, H. G., & Hay, P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.089 · Cited by 36
Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants
Dickerson, J. F., Lynch, F. L., Leo, M. C., DeBar, L., Pearson, J., & Clarke, G. N. (2018) · PEDIATRICS · doi:10.1542/peds.2017-1969 · Cited by 32
Pillai, A., Keyes, K. M., & Susser, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248641 · Cited by 30
Turvey, C., Fuhrmeister, L. A., Klein, D. M., Moeckli, J. K., Howren, M. B., & Chasco, E. E. (2021) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2020.0395 · Cited by 22
“27 Finally, concerns about patient portals jeopardizing the safety of patient or provider must be addressed directly, particularly in light of the stigma around mental health, which exaggerates the strength of its association with violence.”
Bhat, S., Kroehl, M., Trinkley, K. E., Chow, Z., Heath, L. J., Billups, S. J., & Loeb, D. F. (2018) · Population Health Management · doi:10.1089/pop.2017.0144 · Cited by 25
“Reasons for self-discontinuation include lack of immediate treatment effects, adverse effects, worsening depressive symptoms, and suicidal ideations.(11,12) Unfortunately, most patients fail to inform their PCP of treatment self-discontinuation in a timely manner, if at all, and as a result, suffer from untreated MDD.”
BackgroundCrescenzo, F. D., Giorgi, R. D., Garriga, C., Liu, Q., Fazel, S., Efthimiou, O., Hippisley‐Cox, J., & Cipriani, A. (2024) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.194 · Cited by 26
Mathew, S. J., Cutler, A. J., Visitacion, N. C., Gold, M., Yuan, J. X. ‐., & Aurora, B. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001967 · Cited by 15
Cochrane, S. K., Dale, A. M., Buckner‐Petty, S., Sobel, A. D., Lippold, B., & Calfee, R. P. (2020) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2020.10.012 · Cited by 13
Saito, Y., Matsuzu, K., Takami, H. E., Matsui, A., Kuga, Y., Ohara, R., Yoshioka, K., Masaki, C., Akaishi, J., Hames, K. Y., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70123 · Cited by 12
“In other diseases, factors such as age, 19–21 sex, 20,21 and residing a long distance from the hospital 22 have been reported as risk factors for loss to follow-up.”
BackgroundPredictors of successful discontinuation of antipsychotics and antidepressants
Lincoln, T. M., Sommer, D., Quazzola, M., Witzgall, T., & Schlier, B. (2021) · Psychological Medicine · doi:10.1017/s0033291721005146 · Cited by 13
Kazdin, A. E., Harris, M., Hwang, I. H., Sampson, N. A., Stein, D. J., Viana, M. C., Vigo, D., Wu, C., Aguilar‐Gaxiola, S., Alonso, J., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002507 · Cited by 35
“…insurance, ethnic minority status, younger age, and comorbid anxiety and/substance use are associated with discontinuation (Akincigil et al., 2007; Bambauer, Soumerai, Adams, Zhang, & Ross-Degnan, 2007; Ji & Hong, 2020; Samples & Mojtabai, 2015; Warden, Rush, Trivedi, Fava, & Wisniewski, 2007).”
BackgroundImportance of achieving rapid treatment response in major depressive disorder
Alva, G. (2023) · CNS Spectrums · doi:10.1017/s1092852923002213 · Cited by 12
Lippold, B., Tarkunde, Y. R., Cheng, A. L., Hannon, C. P., Adelani, M. A., & Calfee, R. P. (2022) · Arthroplasty Today · doi:10.1016/j.artd.2022.01.032 · Cited by 10
Group Intervention for Young Adults With Mood and Anxiety Disorders Transitioning to College
Chugani, C. D., Goldstein, T. R., Salk, R. H., Poling, K., Sakolsky, D. J., & Brent, D. A. (2020) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000456 · Cited by 11
Pharmaceutical Care in Depression: A Survey of Stigma, Confidence, Attitudes, and Barriers
Soliman, M. M. (2020) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s273365 · Cited by 10
Tiem, J. M. V., Moeckli, J. K., Suiter, N., Fuhrmeister, L. A., Pham, K., Dindo, L. N., & Turvey, C. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.02.018 · Cited by 12
Yang, L., Wu, Z., Cao, L., Wang, Y., Su, Y., Huang, J., Fang, M., Yao, Z., Wang, Z., Wang, F., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.03.063 · Cited by 9
Turvey, C., Fuhrmeister, L., Klein, D. M., McCoy, K. D., Moeckli, J., Steffensmeier, K. R. S., Suiter, N., & Tiem, J. V. V. (2023) · JMIR Formative Research · doi:10.2196/51277 · Cited by 10
“To improve antidepressant adherence, providers need effective tools to address reasons for self-discontinuation [8].”
BackgroundThorpe, D., Strobel, J. E., & Bidargaddi, N. P. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-02091-2 · Cited by 5
“…is not the sole factor predicting non-adherence, nor do “lower-risk” diagnoses and psychiatric medications necessarily result in less risk to people’s health if they abruptly discontinue; namely antidepressants [7, 13, 17, 18, 21, 22], which are prescribed to an increasing share of the population.”
BackgroundSeifert, J., Grohmann, R., Toto, S., Reinhard, M. A., Bleich, S., Erfurth, A., Schüle, C., Stübner, S., & Glocker, C. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04900-7 · Cited by 5
“In fact, ADRs are one of the most commonly reported reasons for self-discon-tinuation of psychotropic drugs among patients with mental disorders (Samples and Mojtabai 2015; Velligan et al. 2017).”
Stephenson, J. J., Touya, M., Chrones, L., Pandya, S. A., Teng, C., & Clayton, A. H. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100750 · Cited by 4
Effectiveness of mental therapy for poor medication adherence in depression: A review
Xu, S., Liu, B., & Zhang, Y. (2020) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v19i8.30 · Cited by 3
“Twenty two percent of patients taking antidepressants withdrew medication without the suggestion from their doctors [10].”
BackgroundA rating scale to inform successful discontinuation of antipsychotics and antidepressants
Lincoln, T. M., Sommer, D., Könemund, M., & Schlier, B. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113768 · Cited by 3
Improving the Therapeutic Relationship When Prescribing Antidepressants: A Pilot Study
Michel, K., Lutz-Beck, D., & Engeroff, S. (2023) · Healthcare · doi:10.3390/healthcare11212825 · Cited by 2
Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?
Gidal, B. E., Rehman, R., Tran, T. T., & Karasov, A. O. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109335 · Cited by 2
“This could occur because of poor medication adherence [11,12], both of which would lead to lower average plasma drug concentrations.”
BackgroundJavier, S. J., Risbud, R. D., Rossi, F. S., Slightam, C. A., Aikens, J. E., Guetterman, T. C., Piette, J. D., & TRIVEDI, R. B. (2023) · Chronic Illness · doi:10.1177/17423953231175690 · Cited by 3
Richards, C. (2018) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2018-13304 · Cited by 2
“Adverse side effects associated with use of antidepressant medications are also problematic as they represent the leading reason for treatment discontinuation (Samples & Mojtabai, 2015).”
BackgroundEnhancing Treatment Engagement in Older Adults
Sirey, J. A., & Marino, P. (2020) · Wiley eBooks · doi:10.1002/9781119129530.ch20 · Cited by 2
Lahouaoula, I., Li, V. W., Scott, A., Do, A., Michalak, E. E., Murphy, J., Huang, S., & Lam, R. W. M. (2021) · medRxiv · doi:10.1101/2021.09.29.21264324 · Cited by 1
“…effects, including sexual dysfunction and weight gain; cost; adverse effects with long-term use of antidepressants (e.g., osteoporosis, gastrointestinal bleeding, and risk of drug interactions with medications for other medical conditions); and patient preference for non-medication treatments [8].”
Pasterkiewicz, U. B. (2017) · UWSpace (University of Waterloo) · Cited by 1
The two sides of the coin of psychosocial stress: evaluation by positron emission tomography
Feltes, P. K. (2018) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Poor sleep in medicated patients with remitted depressive disorder: A naturalistic study
Lee, I., Lu, T., Chen, P. S., Chen, K., & Yang, Y. K. (2020) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_10_20
“But most depressive patients using antidepressants are unable to maintain treatment for this duration due to side effects, unresolved symptoms, residual symptoms, and comorbidity, leading to poor treatment efficacy [7, 8].”
BackgroundSelf-discontinuation of antidepressants common
(2015) · PharmacoEconomics & Outcomes News · doi:10.1007/s40274-015-2151-5
P.023 Sexual dysfunction in patients with major depression: A comparison between 12 antidepressants
Valdés-Florido, M. J., Cauqui, C. M., Pérez-Romero, A., Gallego, F. J. P., & Guillena, S. L. R. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.089
Depression: Third Wave Case Conceptualization
Zuo, Z., & Segal, Z. V. (2022) · Springer eBooks · doi:10.1007/978-3-031-11677-3_17
Hellerstein, O. S., Lahouaoula, I., Li, V. W., Scott, A., Do, A., Michalak, E. E., Murphy, J., Huang, S., Evans, V. K., & Lam, R. W. M. (2025) · Cureus · doi:10.7759/cureus.98278
Thorpe, D., Strobel, J. E., & Bidargaddi, N. P. (2024) · Figshare · doi:10.6084/m9.figshare.26565051
Navigating the Complexities of Treatment-Resistant Depression in Late Life
Cross, C. B., Hristidis, V. C., & Lenze, E. J. (2026) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20260010
Metadata
- Authors
- Samples, H., & Mojtabai, R.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Psychiatric Services
- Published
- 2015-05-01
- Volume
- 66
- Issue
- 5
- Pages
- 455-462
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W2119285370
- Cited by
- 45
- References
- 51
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 7 · 2019: 1 · 2018: 4 · 2017: 6 · 2016: 1 · 2015: 1
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (T32HS000029)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- medication non-adherence, antidepressants, physician recommendations, anxiety disorders, substance use disorders, insurance type, antidepressant side effects, treatment benefit, Collaborative Psychiatric Epidemiology Surveys
- MeSH terms
- Adolescent, Adult, Aged, Antidepressive Agents, Cooperative Behavior, Depressive Disorder, Female, Humans, Male, Middle Aged, Patient Compliance, Practice Patterns, Physicians', Socioeconomic Factors, United States, Health Care Surveys, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.